A Vermont health center asked a 340B dispute resolution panel to reject AstraZeneca's motion to stay the proceedings.

Health Center Opposes AstraZeneca’s Motion to Pause 340B Dispute Resolution Proceedings Over Company’s Contract Pharmacy Policy

A Vermont community health center that co-initiated 340B administrative dispute resolution (ADR) proceedings against AstraZeneca over its conditions on 340B contract pharmacy yesterday asked the panel hearing its claim to deny the drug company’s motion to stay the proceedings.

Little Rivers Health Care, together with Open Door Community Health Centers in California, FamilyCare Health Center in West Virginia, and Ryan White Clinics for 340B Access (RWC-340B), filed the ADR petition against AstraZeneca in January 2021. They want the panel to declare that Astra’s policy of letting covered entities buy its drugs at the 340B price only through just one on-site dispensing pharmacy or through just one designated contract pharmacy violates the 340B statute.

A Vermont community health center that co-initiated 340B administrative dispute resolution (ADR) proceedings against AstraZeneca over its conditions on 340B contract pharmacy yesterday asked the panel hearing its claim to deny the drug company’s motion to stay the proceedings.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report